Regent Peak Wealth Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Regent Peak Wealth Advisors LLC
- $449 Million
- Q4 2024
A detailed history of Regent Peak Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Regent Peak Wealth Advisors LLC holds 556 shares of VRTX stock, worth $260,891. This represents 0.05% of its overall portfolio holdings.
Number of Shares
556
Previous 556
-0.0%
Holding current value
$260,891
Previous $223,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,718Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.22 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...